Related by context. Frequent words. (Click for all words.) 65 Ligands 65 Small Molecule 64 Recombinant Human 64 Epithelial 63 Announces FDA Clearance 63 Oligonucleotide 63 Inflammatory Diseases 63 Phosphorylation 63 Develop Novel 63 Epidermal Growth Factor Receptor 63 RNA Interference 62 Nucleic Acid 62 Overexpression 62 Kinases 62 Monoclonal Antibody 62 FDA Clears 61 Inhibits 61 Drug Shows Promise 61 cell adhesion molecule 61 Atopic Dermatitis 61 Drug Candidate 61 Inactivation 60 Intracellular 60 Small Molecules 60 Polymorphisms 60 Neuronal 60 Autoimmune Disease 60 Completes Enrollment 60 receptor tyrosine kinase 59 By CHRIS WOODKA 59 Immune Cells 59 Receives Orphan Drug Designation 59 Initiates Phase II 59 RNAi Therapeutics 59 Antigens 59 Receives FDA Clearance 59 Flow Cytometry 59 Modulators 59 Molecular Diagnostic 58 Clinical Trial Results 58 autoimmune inflammatory 58 Anti Inflammatory 58 Child Adolesc Psychiatry 58 Single Dose 58 Autoimmune Diseases 58 Prolactin 58 Gene Mutation 58 Survivin 58 Presents Positive 58 Oxidative Stress 58 hypoxia inducible factor 58 ERK1 2 58 Introduces Revolutionary 58 Amino Acid 58 Kinase 58 poly ADP ribose polymerase 58 Tumor Growth 58 Patient Enrollment 57 * Azixa 57 Gastric Cancer 57 Cancer Cells 57 phosphatidylinositol 3 57 Preclinical Data 57 Patent Covering 57 Gene Expression 57 therapeutic monoclonal antibodies 57 Antifungal 57 Awarded Patent 57 Chiral 57 selective inhibition 57 Cardiovascular Monitoring 57 BOHANNAN 57 Proprietary Products 57 Suppresses 57 specific ZFP Nucleases 57 Biomarker Discovery 57 Significantly Improves 57 Enzymatic 57 Reduces Risk 57 Cancer Immunotherapy 56 Hepatitis C Virus HCV 56 Monoclonal Antibodies 56 Commences Phase 56 Introduces Next Generation 56 Proteomic 56 Induces 56 Lipoprotein 56 Inc Therapeutic Competitors 56 Meets Primary Endpoint 56 Polymorphism 56 J Clin 56 Myelodysplastic Syndromes 56 Antisense 56 J Am Acad 56 Agios Pharmaceuticals 56 Announces Immediate Availability 56 Cancer Vaccines 56 C Reactive Protein 56 Transcriptional 56 Phase III Clinical Trial 56 Technol